Menu
Create an Account
Log in
Home
Activities
Live Courses and Conferences
HIV Virtual Courses
Earn CME From On-Demand Webcasts
Sexual Health, HIV Prevention, and Primary Care in 2019
New York, NY
Conference on Retroviruses and Opportunistic Infections
The 2020 Ryan White HIV/AIDS Program CLINICAL CONFERENCE
About IAS–USA Courses
Webinars
Upcoming Webinars
2021 On-Demand Webinars
Earn CME From On-Demand Webinars
About Webinars
COVID-19 Dialogue Series
Upcoming Dialogues
On-Demand Dialogues
Topics in Antiviral Medicine
Current Issues
Previous Issues
TAM
Policies and Practices
Resources
Guidelines
HIV Drug Resistance Mutations
Podcasts
On-Demand Webcasts
Slides
Research Collaboration
Useful Resources for COVID-19 Information and Guidance
Practice Question of the Week
Fellow/Student Resources
Other Resources
About
Mission
Core Faculty
IAS–USA Board of Directors
Staff
CME
Funding Information
Careers
Donate
Website Policies
FAQs
Contact
Topics in Antiviral Medicine
™
loading...
December 2020/January 2021
Volume 28, Issue 3
Download here
, or select individual articles
Go to posttest
Perspective
Vaccination and Immunoprotection in People with HIV
Steven C. Johnson, MD
Physical Function and Frailty in HIV
Kristine M. Erlandson, MD, MS
Management and Prevention of HIV Among Transgender Adults
Asa E. Radix, MD, PhD, MPH
Topics in Antiviral Medicine™
Current Issues
Previous Issues
TAM
Policies and Practices
TAM
Author and Contributor Guidelines
Topics in Antiviral Medicine
Editorial Board
Home
Activities
Live Courses and Conferences
HIV Virtual Courses
Earn CME From On-Demand Webcasts
Sexual Health, HIV Prevention, and Primary Care in 2019
New York, NY
Conference on Retroviruses and Opportunistic Infections
The 2020 Ryan White HIV/AIDS Program CLINICAL CONFERENCE
About IAS–USA Courses
Webinars
Upcoming Webinars
2021 On-Demand Webinars
Earn CME From On-Demand Webinars
About Webinars
COVID-19 Dialogue Series
Upcoming Dialogues
On-Demand Dialogues
Topics in Antiviral Medicine
Current Issues
Previous Issues
TAM
Policies and Practices
Resources
Guidelines
HIV Drug Resistance Mutations
Podcasts
On-Demand Webcasts
Slides
Research Collaboration
Useful Resources for COVID-19 Information and Guidance
Practice Question of the Week
Fellow/Student Resources
Other Resources
About
Mission
Core Faculty
IAS–USA Board of Directors
Staff
CME
Funding Information
Careers
Donate
Website Policies
FAQs
Contact
Practice Question of the Week
June 14, 2021: Gonococcal Infection Treatment
A 33-year-old man with well-controlled HIV infection was diagnosed with gonococcal infection by his primary HIV practitioner. STI testing had been ordered by the patient’s primary HIV practitioner at a telehealth visit. However, the primary practitioner’s office is not open for in-person visits, and so the patient is referred to your sexual health center for treatment. He brings the results of gonorrhea and chlamydia nucleic acid amplification testing, which show positive oropharyngeal testing for gonorrhea and negative chlamydia oropharyngeal testing. Also negative are rectal and urine gonorrhea and chlamydia testing, as well as syphilis treponemal testing. How do you manage this patient according to the updated Centers for Disease Control and Prevention (CDC) recommendations from December 2020?
A. Ceftriaxone 250 mg, followed by a test of cure in 7 to 14 days
B. Ceftriaxone 250 mg, no subsequent test of cure but retesting in 3 months to assess for reinfection
C. Ceftriaxone 500 mg, followed by a test of cure in 7 to 14 days
D. Ceftriaxone 500 mg, no subsequent test of cure but retesting in 3 months to assess for reinfection
Watch Webcast
View Related Resources
Leave Feedback
Subscribe
CLOSE